ProfileGDS4718 / 243502_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 19% 21% 74% 15% 16% 23% 25% 19% 9% 9% 15% 10% 29% 27% 23% 19% 19% 22% 25% 39% 20% 17% 15% 22% 15% 21% 13% 22% 8% 27% 29% 42% 16% 20% 30% 28% 20% 17% 17% 67% 16% 23% 29% 24% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]4.1043219
GSM549102patient 115, normal, homogenized [OPG study]4.2061721
GSM549104patient 119, normal, homogenized [OPG study]7.3051774
GSM549108patient 138, normal, homogenized [OPG study]3.9903915
GSM549119patient 077, normal, homogenized [OPG study]4.0193816
GSM549133patient 032, cancer, homogenized [OPG study]4.2190823
GSM549139patient 042, cancer, homogenized [OPG study]4.3147525
GSM549099patient 107, normal, homogenized [OPG study]4.1169519
GSM549109patient 139, normal, homogenized [OPG study]3.760829
GSM549110patient 046, normal, homogenized [OPG study]3.750989
GSM549114patient 063, normal, homogenized [OPG study]3.9174615
GSM549122patient 082, normal, homogenized [OPG study]3.8062610
GSM549134patient 033, cancer, homogenized [OPG study]4.5014629
GSM549136patient 036, cancer, homogenized [OPG study]4.3759827
GSM549140patient 044, cancer, homogenized [OPG study]4.2080723
GSM549111patient 047, normal, homogenized [OPG study]4.0962919
GSM549113patient 057, normal, homogenized [OPG study]4.0460519
GSM549132patient 031, cancer, homogenized [OPG study]4.202722
GSM549137patient 038, cancer, homogenized [OPG study]4.3165625
GSM549142patient 047, cancer, homogenized [OPG study]5.0626139
GSM549100patient 110, normal, homogenized [OPG study]4.1547320
GSM549107patient 135, normal, homogenized [OPG study]4.0137317
GSM549115patient 068, normal, homogenized [OPG study]3.9155715
GSM549116patient 072, normal, homogenized [OPG study]4.1820122
GSM549120patient 078, normal, homogenized [OPG study]3.9565115
GSM549131patient 030, cancer, homogenized [OPG study]4.1212721
GSM549118patient 074, normal, homogenized [OPG study]3.904113
GSM549129patient 027, cancer, homogenized [OPG study]4.2514722
GSM549123patient 088, normal, homogenized [OPG study]3.722728
GSM549124patient 006, cancer, homogenized [OPG study]4.4388327
GSM549126patient 015, cancer, homogenized [OPG study]4.4660429
GSM549128patient 025, cancer, homogenized [OPG study]5.0671542
GSM549103patient 117, normal, homogenized [OPG study]4.0488316
GSM549117patient 073, normal, homogenized [OPG study]4.1284620
GSM549138patient 041, cancer, homogenized [OPG study]4.5118430
GSM549141patient 045, cancer, homogenized [OPG study]4.4044428
GSM549130patient 028, cancer, homogenized [OPG study]4.1529120
GSM549101patient 111, normal, homogenized [OPG study]4.0247917
GSM549105patient 128, normal, homogenized [OPG study]4.0568317
GSM549106patient 134, normal, homogenized [OPG study]6.7046667
GSM549112patient 048, normal, homogenized [OPG study]4.0141516
GSM549125patient 011, cancer, homogenized [OPG study]4.2906923
GSM549127patient 024, cancer, homogenized [OPG study]4.4634429
GSM549135patient 035, cancer, homogenized [OPG study]4.2337124